参考文献/References:
[1] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2019[J].CA Cancer J Clin,2019,69(1):7-34.
[2] LU C,XU C F,WAN X Y,et al.Screening for pancreatic cancer in familial high-risk individuals:a systematic review[J].World J Gastroenterol,2015,21(28):8678-8686.
[3] ZHEN D B,RABE K G,GALLINGER S,et al.BRCA1,BRCA2,PALB2,and CDKN2A mutations in familial pancreatic cancer:a PACGENE study[J].Genet Med,2015,17(7):569-577.
[4] MCWILLIAMS R R,WIEBEN E D,CHAFFEE K G,et al.CDKN2A germline rare coding variants and risk of pancreatic cancer in minority populations[J].Cancer Epidemiol Biomarkers Prev,2018,27(11):1364-1370.
[5] CAMPA D,PASTORE M,GENTILUOMO M,et al.Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk[J].Oncotarget,2016,7(35):57011-57020.
[6] LEOF E R,ZHU X,RABE K G,et al.Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result[J].Genet Med,2019,21(11):2468-2477.
[7] 熊慧敏,许小凡,段丽芳,等.白细胞介素-6在胰腺炎症和肿瘤中的作用机制研究进展[J].新乡医学院学报,2019,36(12):1191-1196.
[8] GRANT R C,SELANDER I,CONNOR A A,et al.Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer[J].Gastroenterology,2015,148(3):556-564.
[9] HUANG J Y,BUTLER L M,WANG R,et al.Dietary intake of one-carbon metabolism-related nutrients and pancreatic cancer risk:the Singapore Chinese health study[J].Cancer Epidemiol Biomarkers Prev,2016,25(2):417-424.
[10] SASAKI S,KITAGAWA Y,SEKIDO Y,et al.Molecular processes of chromosome 9p21 deletions in human cancers[J].Oncogene,2003,22(24):3792-3798.
[11] GUL A,LEYLAND-JONES B,DEY N,et al.A combination of the PI3K pathway inhibitor plus cell cycle pathway inhibitor to combat endocrine resistance in hormone receptor-positivebreast cancer:a genomic algorithm-based treatment approach[J].Am J Cancer Res,2018,8(12):2359-2376.
[12] 刘梦桐,柳剑英,苏静.CDKN2A基因在黑色素瘤中的研究现状[J].中华病理学杂志,2019,48(11):909-912.
[13] PADHI S S,ROY S,KAR M,et al.Role of CDKN2A/p16 expre-ssion in the prognostication of oral squamous cell carcinoma[J].Oral Oncol,2017,73:27-35.
[14] HATZISTERGOS K E,WILLIAMS A R,DYKXHOORN D,et al.Tumor suppressors RB1 and CDKN2a cooperatively regulate cell-cycle progression and differentiation during cardiomyocyte deve-lopment and repair[J].Circ Res,2019,124(8):1184-1197.
[15] 方乐平,徐晓燕,姬玉,等.胰腺癌术后影响患者预后的相关因素分析[J].中华医学杂志,2018,98(8):606-611.
相似文献/References:
[1]李 丽,赵江海.立体定向低分割适形放射治疗胰腺癌38 例临床观察与护理[J].新乡医学院学报,2006,23(06):626.
[2]刘宝军,周建华,包金英.替吉奥用于转移性胰腺癌治疗的研究进展[J].新乡医学院学报,2012,29(01):000.
[3]彭青侠,许小凡,段丽芳,等.细胞外囊泡在胰腺癌中的作用研究进展[J].新乡医学院学报,2021,38(9):893.[doi:10.7683/xxyxyxb.2021.09.021]
[4]熊慧敏,许小凡,段丽芳,等.白细胞介素-6在胰腺炎症和肿瘤中的作用机制研究进展[J].新乡医学院学报,2019,36(12):1191.[doi:10.7683/xxyxyxb.2019.12.022]
[5]田龙夫,崔云峰,张 琦,等.天然植物中生物碱类药物抗胰腺癌作用的研究进展[J].新乡医学院学报,2018,35(4):343.[doi:10.7683/xxyxyxb.2018.04.023]
N/A.N/A[J].Journal of Xinxiang Medical University,2018,35(6):343.[doi:10.7683/xxyxyxb.2018.04.023]
[6]贾如江,侯丽艳,尹清臣,等.轴突诱导因子4D和血管内皮生长因子在胰腺癌组织中的表达[J].新乡医学院学报,2016,33(11):950.[doi:10.7683/xxyxyxb.2016.11.004]
JIA Ru-jiang,HOU Li-yan,YIN Qing-chen,et al.Clinical significance of the expression of semaphorin 4D and vascular endothelial growth factor in pancreatic carcinoma[J].Journal of Xinxiang Medical University,2016,33(6):950.[doi:10.7683/xxyxyxb.2016.11.004]